Anti-5-Hydroxytryptamine Receptor 4 (extracellular)
Ó¢ÎÄÃû³Æ£º Anti-5-Hydroxytryptamine Receptor 4 (extracellular)
ÐͺÅ:null    ¿¹Ìå»õºÅ£º ASR-036-25ul
¼Û¸ñ:ÇëÖµ磺010-57128832,18610462672
Æ·ÅÆ: alomone    ²úÆ·É̱ê: alomone

 

åµÄ½»²æ·´Ó¦£ºÈË£¬Ð¡Ê󣬴óÊ󣬼¦ £¬¹·£¬Öí£¬Ñò£¬Å££¬ÍõÈ......
²úÆ·ÓÃ;£º¿ÆÑРʵÑ飬ÓÃÓÚÃâÒß×黯ʵÑ飬WBʵÑ飬ÏàÓ¦µÄ±ê¼Ç¿¹ÌåÓÐHRP±ê¼Ç¿¹Ì壬FITC±ê¼Ç£¬BIOµÈ¡£
Ó¦ÓÃÁìÓò£º Western blotting¡¢Immunohistocry¡¢ELISA¡¢IF¡¢IHC-P¡¢IHC-FµÈ£¬¾ßÌåÊÊÓõÄʵÑéÇëÀ´µç×Éѯ£¬±¾¹«Ë¾ÓÐͬһ²úÆ·ÊÊÓÃÓÚ²»Í¬ÊµÑéµÄ¿¹Ìå¡£
±£´æÌõ¼þ£º Store at -20¡æ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at roomtemperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.40.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4¡æ.
SCNN1B¿¹Ìå ÉÏÆ¤ÄÆÍ¨µÀβ¿¹ÌåÉϺ£ÑÓĽ³¤ÆÚ¹©Ó¦ÃâÒß×黯¿¹Ìå¡¢WB¿¹Ìå¡¢ÃâÒß×黯ÊÔ¼ÁºÐºÍ¿¹ÌåÊÔÑéËùÐèÈ«²¿Ïà¹ØÊÔ¼Á¡¢Ó«¹â±ê¼Ç¿¹Ìå¡¢elisa¿¹Ìå¡¢µ¥¿Ë¡¿¹Ìå¡¢¶à¿Ë¡¿¹Ìå¡¢¸÷ÖÖ±ê¼ÇµÄ¶þ¿¹IgG/IgM/IgD/IgAµÈ¿ÆÑÐʵÑ鿹Ìå¡£


SCNN1B¿¹Ìå ÉÏÆ¤ÄÆÍ¨µÀβ¿¹Ìå>> Ïà¹Ø²úÆ·×Éѯ!
P-cadherin¿¹Ìå P-¸ÆÕ³¸½·Ö×Ó¿¹Ìå
PACAP-38¿¹Ìå ÏÙÜÕËá»·»¯Ã¸¼¤»îëÄ-38¿¹Ìå
P53 protein(wt-p53)¿¹Ìå Ö×ÁöÒÖÖÆ»ùÒòP53µ°°×¿¹Ì壨ҰÉúÐÍP53£©
P51A¿¹Ìå Ö×ÁöÒÖÖÆ»ùÒòp63α¿¹Ìå
PDE4A8¿¹Ìå ***Ëá¶þõ¥Ã¸4A8¿¹Ìå
PDGF AB+BB¿¹Ìå ѪС°åÔ´ÐÔÉú³¤Òò×ÓAB+BB¿¹Ìå
PCNA [Proliferation Marker]¿¹Ìå Ôöֳϸ°ûºË¿¹Ô­¿¹Ìå
PCP4¿¹Ìå ÄÔÌØÒìÐÔ¶àëĵ°°×19¿¹Ìå
P2RX4¿¹Ìå Èý***ËáÏÙÜÕÃÅ¿ØÑôÀë×ÓͨµÀµ°°×¿¹Ìå
Peroxiredoxin 2¿¹Ìå ÁòÑõ»¹µ°°×¹ýÑõ»¯Îïø¢ò/ÛÏ»ù¿¹Ñõ»¯µ°°×¿¹Ìå
p53 apoptosis effector related to PMP22¿¹Ìå p53µòÍöÏà¹Ø×÷Óõ°°×PMP22¿¹Ìå
PAICS¿¹Ìå ***ËáºËÌǰ·ßäßòôÈ»¯Ã¸¿¹Ìå
p75 NGF Receptor¿¹Ìå Éñ¾­Éú³¤Òò×ÓÊÜÌ忹Ìå
AMPKγ2¿¹Ìå ÏÙÜÕµ¥***Ëá»î»¯µ°°×¼¤Ã¸γ2¿¹Ìå
PAFAH1B2¿¹Ìå ѪС°åÑÜ»¯Éú³¤Òò×Óβ¿¹Ìå
PAFAHG¿¹Ìå ѪС°åÑÜ»¯Éú³¤Òò×Óγ¿¹Ìå
p47¿¹Ìå ѪС°å47µ°°×¿¹Ìå
PAPP A2¿¹Ìå ÈÑÉïÏà¹ØÑª½¬µ°°×A2¿¹Ìå
PGCP¿¹Ìå Ѫ½¬¹È°±ËáôÈëÄø¿¹Ìå
phospho-P53(Ser315)¿¹Ìå ***ËữÖ×ÁöÒÖÖÆ»ùÒòP53¿¹Ìå
Pokemon¿¹Ìå **Ãɵ°°×¿¹Ìå
PALB2¿¹Ìå ÈéÏÙ°©Ò׸лùÒòÏà¹Øµ°°×2
Parvalbumin¿¹Ìå ϸСÇåµ°°×¿¹Ìå
PIGA¿¹Ìå ºìϸ°û***Ö¬õ£¼¡´¼¾ÛÌÇA¿¹Ìå
PCDHA11¿¹Ìå Ô­¸ÆÕ³µ°°×11¿¹Ìå
PKN2¿¹Ìå µ°°×¼¤Ã¸N2¿¹Ìå
GRK2¿¹Ìå Gµ°°×żºÏÊÜÌ弤ø2¿¹Ìå
PHC2¿¹Ìå ÔçÆÚ·¢Óýµ÷¿Øµ°°×2¿¹Ìå
Phospholipase C beta 3¿¹Ìå ***õ¥Ã¸Cβ3
PAPOLB¿¹Ìå ØºÍèÌØÒìÐÔºËÜÕËá¹ûÌÇβ¿¹Ìå
C11orf73¿¹Ìå 11ºÅȾɫÌ忪·ÅÔĶÁ¿ò73¿¹Ìå
PCYT1A ¿¹Ìå ***ËáÒÒ´¼°·×ªÒÆÃ¸A¿¹Ìå
Prostaglandin I2 Receptor¿¹Ìå ǰÁл·ËØÊÜÌ忹Ìå
PCDH7¿¹Ìå Ô­¸ÆÕ³µ°°×7¿¹Ìå
PXMP1¿¹Ìå ¹ýÑõ»¯ÎïøĤµ°°×1¿¹Ìå
Plakophilin 2¿¹Ìå ÇÅÁ£°ß·ÆËص°°×2¿¹Ìå
PSCDBP¿¹Ìå °ûÕ³µ°°×½áºÏµ÷½Úµ°°×¿¹Ìå
PCTAIRE2¿¹Ìå Ë¿°±Ëá/ËÕ°±Ëáµ°°×¼¤Ã¸PCTK2¿¹Ìå
PDE7A¿¹Ìå ***Ëá¶þõ¥Ã¸7¿¹Ìå
PDE7B¿¹Ìå ***Ëá¶þõ¥Ã¸7B¿¹Ìå
PHOX2A¿¹Ìå ÏÈÌìÐÔÑÛÍ⼡ÏËά»¯Ïà¹Øµ°°×FEOM2¿¹Ìå
PHOX2B¿¹Ìå Éñ¾­Ä¸Ï¸°ûÁöµ°°×PHOX2B¿¹Ìå
p35¿¹Ìå ϸ°ûÖÜÆÚµ°°×ÒÀÀµÐÔ¼¤Ã¸5¼¤»îÒò×Ó1¿¹Ìå
p16 ARC¿¹Ìå ¼¡¶¯µ°°×Ïà¹Øµ°°×2/3¸´ºÏÌåÑÇ»ù5¿¹Ìå
Puratrophin 1¿¹Ìå ÆÖ¿ÏҰϸ°ûήËõÏà¹Øµ°°×1¿¹Ìå
PLEKHG5¿¹Ìå µòÍöÓÕµ¼ÊÜÌåPLEKHG5¿¹Ìå
PPP2R2B/PP2A-B55¿¹Ìå µ°°×ÖÊ***Ëáø2A-B55¿¹Ìå
PPT2¿¹Ìå רéµõ£µ°°×Ë®½âø2¿¹Ìå
PQBP1¿¹Ìå ¶à¹È°±õ£°·½áºÏµ°°×1¿¹Ìå


Ïà¹Ø±êÇ©£ºµ°°×¿¹Ìå ±ê¼Ç¿¹Ìå ¿¹Ì忹ԭ "